The estimated Net Worth of Nathaniel Sisitsky is at least $2.08 Milion dollars as of 1 March 2023. Mr. Sisitsky owns over 5,333 units of Nuvasive Inc stock worth over $947,640 and over the last 9 years he sold NUVA stock worth over $0. In addition, he makes $1,136,560 as Senior Vice President, General Counsel oraz Corporate Secretary at Nuvasive Inc.
Nathaniel has made over 7 trades of the Nuvasive Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 5,333 units of NUVA stock worth $211,987 on 1 March 2023.
The largest trade he's ever made was exercising 8,029 units of Nuvasive Inc stock on 1 March 2022 worth over $319,153. On average, Nathaniel trades about 1,844 units every 122 days since 2016. As of 1 March 2023 he still owns at least 23,840 units of Nuvasive Inc stock.
You can see the complete history of Mr. Sisitsky stock trades at the bottom of the page.
Nathaniel B. Sisitsky Esq. serves as Senior Vice President, General Counsel, Corporate Secretary of the Company. He has served as our Senior Vice President, General Counsel and Corporate Secretary since June 2018 and is responsible for leadership of NuVasive’s legal team. In this role, Mr. Sisitsky oversees the NuVasive Spine Foundation, and as of January 2020, he also oversees the Company’s Global Risk & Integrity team. Mr. Sisitsky previously served as our Vice President and Associate General Counsel, Corporate Affairs from July 2015 to June 2018. Prior to joining NuVasive, Mr. Sisitsky was Vice President and Associate General Counsel at CareFusion Corporation from April 2009 until April 2015. From August 2004 until April 2009, Mr. Sisitsky served as Vice President, Legal – Corporate Finance at American Tower Corporation. Prior to joining American Tower, Mr. Sisitsky was a Junior Partner in the Corporate Department of Wilmer Cutler Pickering Hale and Dorr (WilmerHale), based in Boston, MA.
As the Senior Vice President, General Counsel oraz Corporate Secretary of Nuvasive Inc, the total compensation of Nathaniel Sisitsky at Nuvasive Inc is $1,136,560. There are 2 executives at Nuvasive Inc getting paid more, with J. Christopher Barry having the highest compensation of $5,425,440.
Nathaniel Sisitsky is 46, he's been the Senior Vice President, General Counsel oraz Corporate Secretary of Nuvasive Inc since 2018. There are 14 older and 4 younger executives at Nuvasive Inc. The oldest executive at Nuvasive Inc is Donald Rosenberg, 69, who is the Independent Director.
Nathaniel's mailing address filed with the SEC is 7475, Lusk Boulevard, San Diego, San Diego County, California, 92121, United States.
Over the last 22 years, insiders at Nuvasive Inc have traded over $60,917,905 worth of Nuvasive Inc stock and bought 185,079 units worth $8,372,956 . The most active insiders traders include Jesse I Treu, James C Blair oraz Brian H Dovey. On average, Nuvasive Inc executives and independent directors trade stock every 11 days with the average trade being worth of $415,308. The most recent stock trade was executed by Marc W. Rosenbaum on 1 March 2023, trading 1,829 units of NUVA stock currently worth $72,703.
nuvasive® is a place where we create new and innovative products at a speed that drives our ability to deliver absolute responsiveness®, and gives us a competitive edge. at nuvasive, we empower our shareowners to influence results and significantly contribute to the success of the company. together we make nuvasive a leader in the spine industry with our unique focus on speed of innovation®. every member of the nuvasive family has the opportunity to improve the lives of patients through their work. these life-changing career paths show how hard work, a competitive spirit and your unwavering dedication to the patient can take you and your career to new places. in addition to being a great place to have a career, we’re also committed to giving back and supporting our communities. through an attitude of gratitude, nuvasive provides life-changing spinal surgery to disadvantaged communities through our nonprofit, the nuvasive spine foundation®, and offers patient-to-patient support through
Nuvasive Inc executives and other stock owners filed with the SEC include: